Intellectus Partners, LLC Abbott Laboratories Transaction History

Intellectus Partners, LLC

$361 Million
Q2 2024

A detailed history of Intellectus Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Intellectus Partners, LLC holds 9,173 shares of ABT stock, worth $1.05 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

9,173

Previous 10,020 8.45%

Holding current value

$1.05 Million

Previous $1.14 Million 16.26%

% of portfolio

0.26%

Previous 0.3%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $85,318 - $95,236	-847 Reduced 8.45%	9,173 $953,000
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $186,950 - $206,478	1,707 Added 20.53%	10,020 $1.14 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $9,199 - $11,260	-102 Reduced 1.21%	8,313 $915,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $10,126 - $12,149	-106 Reduced 1.24%	8,415 $814,000
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $201 - $224	2 Added 0.02%	8,521 $928,000
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $193 - $228	2 Added 0.02%	8,519 $862,000
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.02%	8,517 $935,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $43,154 - $49,965	446 Added 5.53%	8,515 $824,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $431,041 - $520,991	-4,223 Reduced 34.36%	8,069 $877,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $76,849 - $93,712	-674 Reduced 5.2%	12,292 $1.46 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $21,141 - $25,887	-183 Reduced 1.39%	12,966 $1.82 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $233 - $258	2 Added 0.02%	13,149 $1.55 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $49,509 - $58,280	468 Added 3.69%	13,147 $1.52 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $108 - $128	-1 Reduced 0.01%	12,679 $1.52 Million
Q4 2020 Feb 18, 2021	BUY	$105.0 - $114.42 $1.26 Million - $1.37 Million	12,007 Added 1784.1%	12,680 $1.39 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.22 Million - $1.33 Million	-11,607 Reduced 94.52%	673 $1.39 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $140,575 - $170,718	-1,534 Reduced 11.1%	12,280 $1.34 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $50,919 - $65,170	665 Added 5.06%	13,814 $1.26 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $340,986 - $498,616	5,428 Added 70.3%	13,149 $1.04 Million
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $606,175 - $674,815	7,721 New	7,721 $671,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $1,324 - $1,601	-20 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $61,233 - $69,368	-934 Reduced 97.9%	20 $1,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $8,170 - $9,118	-170 Reduced 15.12%	954 $51,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,124	1,124 $55,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Abbott Laboratories Transaction History